DUPIXENT was studied in the following trials:
| Parameter | DRI12544 study (776 patients) |
QUEST study (1902 patients) |
VENTURE study (210 patients) |
|---|---|---|---|
| Mean age | 49 years | 48 years | 51 years |
| Female | 63% | 63% | 61% |
| White | 78% | 83% | 94% |